glp 1 agonist lilly to pour $6.5 billion into GLP-1 pill manufacturing site FDA just approved orforglipron (Foundayo),

Since its discovery in 1973, in vivo and in vitro studies have shown that GHK-Cu possesses a wealth of health-positive actions including improving wound contraction and epithelization, and increasing the production of growth factors and activity of antioxidant enzymes

By promoting detoxification, Biomax Bio-Sulforaphane Advanced supports the bodys natural processes to eliminate toxins and maintain overall health

Clinical efficacy in humans is still being researched

FASEB J 15, 16191621

In this must-listen episode of the Modern Thyroid and Wellness Podcast, host McCall McPherson sits down with functional medicine expert Dr